Potential impact of NUCB2 genetic variants with the clinicopathological characteristics of prostate cancer
Yung-Shu Lee, Tien-Huang Lin, Chia-Yen Lin, Shun-Fa Yang, Chiao-Wen Lin, Chih-Hsin Tang · 2026
Read Potential impact of NUCB2 genetic variants with the clinicopathological characteristics of prostate cancer by Yung-Shu Lee, Tien-Huang Lin, Chia-Yen Lin, Shun-Fa Yang, Chiao-Wen Lin, Chih-Hsin Tang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13539920.txt.
Description
Yung-Shu Lee and five colleagues examine, in a 2026 genetic study, whether inherited variants in a gene called NUCB2 relate to how prostate cancer behaves. The gene makes a precursor of nesfatin-1, a protein first found in brain cells that also circulates as a hormone-like signal.
Four variants were compared between patients and healthy men, alongside tumor stage and spread details. Carrying a G letter at one variant site went with lower odds of advanced stage and of cancer invading along nerves. Public tissue data showed that variant also tied to lower NUCB2 levels. The authors read the variant as possibly protective against progression, while noting lifestyle links remain untested.
Catalog record
| CREATOR | Yung-Shu Lee, Tien-Huang Lin, Chia-Yen Lin, Shun-Fa Yang, Chiao-Wen Lin, Chih-Hsin Tang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13997 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |